Ousia™ bioXEN

Sourced from bovine bone mineral and manufactured through a distinctive process, Ousia™ bioXEN bone grafting particulate has the crystalline structure of carbonate apatite, much like the structure of intact human bone. Ousia™ bioXEN allows for a blend of a porous structure for vascular access with a roughened surface that is advantageous to cell adhesion and subsequent bone matrix deposition.

An Osteoconductive Matrix

Surgeons have a biocompatible and safe osteoconductive matrix used for new bone formation in defects.

Ousia™ bioXEN benefits:

• Osteoconductive scaffold is favorable to bone formation
• Porosity of material allows for thorough revascularization
• Particle structure helps to maintain space
• Easy handling of material allows for precise graft placement

 

Proven Results

bioXEN and Bio-Oss® sections taken at 2 months show residual implant material present within the defects. The histology images shown below refer to new bone in apposition to the bioXEN or Bio-Oss® bone mineral matrix. New bone (green) can also be seen adjacent to the mineral, showing evidence of ongoing bone formation in the defect area.

Histological Assessment at 8 weeks (Based on Histology Scores 1-5)

Calcified Bone

Bio-Oss® - 2.5

Ousia™ bioXEN - 3.0

Bone Marrow

Bio-Oss® - 3.5

Ousia™ bioXEN - 3.0

Residual Implant Material

Bio-Oss® - 3.0

Ousia™ bioXEN - 3.0

Ousia™ bioXEN Histology

In vivo studies comparing Ousia™ bioXEN and Bio-Oss® show similarities in performance of these products. In this study, there were no significant differences between the two products.

Bio-Oss® Histology

Bio-Oss® is a registered trademark of Geistlich, Wolhusen, Switzerland.